Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

IF 37.6 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

European Heart Journal Pub Date : 2025-05-20 DOI:10.1093/eurheartj/ehaf222

Massimo Imazio,Cristina Basso,Antonio Brucato,Karin Klingel,Petr Kuchynka,George Lazaros,Marco Merlo,Gianfranco Sinagra,Yehuda Adler,Chiara Bucciarelli Ducci,Matteo Cameli,Silvia Castelletti,Alida Linda Caforio,Lia Crotti,Lorenzo Dagna,Andrea Frustaci,Allan Klein,Johanna Kuusisto,Angela Lopez Sainz,Renzo Marcolongo,Antonis Pantazis,Angelos G Rigopoulos,Arsen Ristic,Petar Seferovic,Mary Sheppard,Carsten Tschöpe,Thomas Lüscher

{"title":"Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.","authors":"Massimo Imazio,Cristina Basso,Antonio Brucato,Karin Klingel,Petr Kuchynka,George Lazaros,Marco Merlo,Gianfranco Sinagra,Yehuda Adler,Chiara Bucciarelli Ducci,Matteo Cameli,Silvia Castelletti,Alida Linda Caforio,Lia Crotti,Lorenzo Dagna,Andrea Frustaci,Allan Klein,Johanna Kuusisto,Angela Lopez Sainz,Renzo Marcolongo,Antonis Pantazis,Angelos G Rigopoulos,Arsen Ristic,Petar Seferovic,Mary Sheppard,Carsten Tschöpe,Thomas Lüscher","doi":"10.1093/eurheartj/ehaf222","DOIUrl":null,"url":null,"abstract":"The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"18 1","pages":""},"PeriodicalIF":37.6000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehaf222","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.

查看原文本刊更多论文

COVID-19疾病和疫苗接种后的肌心包并发症：欧洲心脏病学会心肌和心包疾病工作组的临床共识声明

本欧洲心脏病学会心肌和心包疾病工作组临床共识声明的目的是回顾目前关于冠状病毒病2019 （COVID-19）心肌和心包并发症的流行病学、发病机制、诊断、治疗和结局以及疫苗接种的知识，以提高对这些并发症患者管理的认识和临床信心。在COVID-19疾病和疫苗接种后1个月内发生心外膜并发症的风险尤其高。与该病有关的形式通常比与接种疫苗有关的形式更常见和严重。即使接种COVID-19疫苗会增加心肌炎风险，但接种疫苗的人的这种风险低于未接种疫苗的人，这支持了疫苗的使用。总体而言，与COVID-19相关的并发症，特别是心肌炎，相对罕见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Heart Journal 医学-心血管系统

CiteScore

39.30

自引率

6.90%

发文量

3942

审稿时长

1 months

期刊介绍： The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.